| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |